Solcitinib
CAS: 1206163-45-2
Ref. 3D-GYB16345
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Product Information
Solcitinib is a Jak1 inhibitor that is being evaluated for its potential to treat cancer. The drug inhibits the activity of the Janus kinase 1 (JAK1) enzyme, which is involved in signaling pathways that are important for cell growth and survival. Solcitinib has been shown to inhibit tumor growth in animal models of cancer and has been shown to be well-tolerated in humans with advanced solid tumors who have previously received treatment with other anti-cancer agents. In addition, solcitinib has been shown to reduce inflammation and improve immune function in animal models of inflammatory bowel disease and bowel disease. This drug may also be effective against autoimmune diseases such as alopecia areata or inflammatory bowel disease.
Chemical properties
Technical inquiry about: 3D-GYB16345 Solcitinib
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
